First report of the plasmid-mediated colistin resistance gene mcr-1 in a clinical Escherichia coli isolate in Algeria

2016 ◽  
Vol 48 (6) ◽  
pp. 760-761 ◽  
Author(s):  
Betitera Yanat ◽  
Jesús Machuca ◽  
Radia Dali Yahia ◽  
Abdelaziz Touati ◽  
Álvaro Pascual ◽  
...  
2018 ◽  
Vol 15 ◽  
pp. 169-170 ◽  
Author(s):  
Cemil Kurekci ◽  
Muhsin Aydin ◽  
Ozkan Ufuk Nalbantoglu ◽  
Aycan Gundogdu

2020 ◽  
Vol 21 ◽  
pp. 291-293
Author(s):  
John Mark S. Velasco ◽  
Ma. Theresa G. Valderama ◽  
Katie R. Margulieux ◽  
Paula Corazon S. Diones ◽  
Angeli Mae B. Reyes ◽  
...  

2019 ◽  
Vol 19 ◽  
pp. 356-357 ◽  
Author(s):  
Larbi Zakaria Nabti ◽  
Farida Sahli ◽  
Linda Hadjadj ◽  
Edgarthe Priscilla Ngaiganam ◽  
David Lupande-Mwenebitu ◽  
...  

2019 ◽  
Vol 8 (29) ◽  
Author(s):  
Katrin Zurfluh ◽  
Marc J. A. Stevens ◽  
Melissa Bucher ◽  
Laurent Poirel ◽  
Patrice Nordmann ◽  
...  

Here, we sequenced multidrug resistance plasmid pT3, which encodes mcr-3.5 and other resistance genes. The cooccurrence of mcr genes and other resistance genes on a single plasmid is of concern.


2020 ◽  
Vol 64 (10) ◽  
Author(s):  
Yu-Zhang He ◽  
Teng-Fei Long ◽  
Cai-Ping Chen ◽  
Bing He ◽  
Xing-Ping Li ◽  
...  

ABSTRACT The mobile colistin resistance gene mcr-3 has globally disseminated since it was first reported in 2017 in Escherichia coli. In vitro mobilization assays in this study demonstrate the functionality of the composite transposon structure ISKpn40-mcr-3.11-dgkA-ISKpn40 in wild-type and recA− E. coli strains. These transpositions generated 4-bp duplications at the target sites. This is the first report demonstrating the mobility of the mcr-3.11 gene by transposition.


2017 ◽  
Vol 61 (4) ◽  
Author(s):  
Rainer Hartl ◽  
Heidrun Kerschner ◽  
Sarah Lepuschitz ◽  
Werner Ruppitsch ◽  
Franz Allerberger ◽  
...  

ABSTRACT Since colistin resistance based on the plasmid-encoded mcr-1 gene was first described, this resistance gene in Enterobacteriaceae has been found worldwide. These organisms are typically of heterogeneous genetic background and show exceptional clonal diversity. We describe the first confirmation of mcr-1 in a human Escherichia coli strain cultured from a surveillance stool sample of an Austrian oncology patient.


2016 ◽  
Vol 60 (5) ◽  
pp. 3249-3250 ◽  
Author(s):  
Shimaa S. Elnahriry ◽  
Hazim O. Khalifa ◽  
Ahmed M. Soliman ◽  
Ashraf M. Ahmed ◽  
Alaaddin M. Hussein ◽  
...  

Author(s):  
Deisy J Abril ◽  
Ingrid Gisell Bustos Moya ◽  
Ricaurte Alejandro Marquez-Ortiz ◽  
Diego Fernando Josa Montero ◽  
Zayda Lorena Corredor Rozo ◽  
...  

The carbapenemase OXA-244 is a derivate of OXA-48, and its detection is very difficult in laboratories. Here we report the identification and genomic analysis of an Escherichia coli isolate (28Eco12) harbouring the blaOXA-244 gene identified in Colombia, South America. The 28Eco12 isolate was identified during a retrospective study and it was recovered from a patient treated in Colombia. The complete nucleotide sequence was established using the PacBio platform. A comparative genomics analysis with other blaOXA-244–harbouring Escherichia coli strains was performed. The 28Eco12 isolate belonged to sequence type (ST) 38 and its genome was composed of two molecules, a chromosome of 5,343,367 bp and a plasmid of 92,027 bp, which belonged to the incompatibility group IncY and did not harbour resistance genes. The blaOXA-244 gene was chromosomally-encoded and mobilized by an ISR1-related Tn6237 composite transposon. Notably, this transposon was inserted and located within a new genomic island. For our knowledge this is the first report of a blaOXA-244–harbouring Escherichia coli isolate in American continent.Our results suggest that the introduction of the OXA-244-producing E. coli isolate was through clonal expansion of the ST38 pandemic clone. Other isolates producing OXA-244 could be circulating silently on the American continent.


Sign in / Sign up

Export Citation Format

Share Document